Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SRTS - Sensus Healthcare Inc


IEX Last Trade
6.49
0.030   0.462%

Share volume: 96,149
Last Updated: Fri 30 Aug 2024 09:57:44 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$6.46
0.03
0.46%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
29%
Profitability 6%
Dept financing 6%
Liquidity 74%
Performance 45%
Company vs Stock growth
vs
Performance
5 Days
-0.91%
1 Month
4.65%
3 Months
15.19%
6 Months
45.21%
1 Year
107.64%
2 Year
-47.16%
Key data
Stock price
$6.49
P/E Ratio 
16.08
DAY RANGE
N/A - N/A
EPS 
$0.41
52 WEEK RANGE
$1.79 - $7.18
52 WEEK CHANGE
$1.09
MARKET CAP 
106.857 M
YIELD 
N/A
SHARES OUTSTANDING 
16.389 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
0.72
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$157,557
AVERAGE 30 VOLUME 
$250,048
Company detail
CEO: Joseph Sardano
Region: US
Website: https://sensushealthcare.com/
Employees: 43
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.

Recent news